Data Monitoring and Interim Analyses in the Pharmaceutical Industry: Ethical and Logistical Considerations

Statistics in Medicine - United States
doi 10.1002/sim.4780120512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Stopping Rules, Interim Analyses and Data Monitoring Committees

British Journal of Cancer
Cancer ResearchOncology
1993English

IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Ethical and Legal Considerations in Biometric Data Usage—Bulgarian Perspective

Frontiers in Public Health
EnvironmentalPublic HealthOccupational Health
2018English

Applications of Student Data in Higher Education: Issues and Ethical Considerations

2016English

Text and Data Mining Meets the Pharmaceutical Industry: Markus Bundschus Speaks

Bulletin of the Association for Information Science and Technology
2017English

Microanalysis in the Pharmaceutical and Biomedical Industry

Microscopy and Microanalysis
Instrumentation
2003English

Ethical Considerations in Pathology

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2016English

Functional Connectivity Analyses in Imaging Genetics: Considerations on Methods and Data Interpretation

PLoS ONE
Multidisciplinary
2011English

The Profit Maximizing Liner Shipping Problem With Flexible Frequencies: Logistical and Environmental Considerations

Flexible Services and Manufacturing Journal
Management ScienceIndustrialOperations ResearchManufacturing Engineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy